|1||Active, not recruiting||
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
CD133+ Cell Therapy for Refractory Coronary Heart Disease
Intramyocardial Delivery of Autologous Bone Marrow
Effects of Intracoronary Progenitor Cell Therapy on Coronary Flow Reserve After Acute MI
† Study has passed its completion date and status has not been verified in more than two years.